Although transgender and nonbinary (TNB) people can acquire human papillomavirus (HPV), research examining HPV vaccination in these populations is scarce. TNB individuals experience high levels of gender-related health care discrimination, which may undermine HPV vaccine uptake. Using data from a national online survey (N=716), we found a negative association between gender-related health care discrimination and HPV vaccination among transgender women and nonbinary individuals who were assigned male at birth (AMAB; odds ratio [OR]=0.52; 95% confidence interval [CI]: 0.29–0.93). Addressing gender-related health care discrimination may facilitate HPV vaccination and help prevent HPV-related cancers among transgender women and nonbinary AMAB individuals.
Get full access to this article
View all access options for this article.
References
1.
BrownB, PoteatT, MargL, GaleaJT. Human papillomavirus-related cancer surveillance, prevention, and screening among transgender men and women: neglected populations at high risk. LGBT Health. 2017; 4:315–319.
2.
SinghV, GratzerB, GorbachPM, et al.Transgender women have higher human papillomavirus prevalence than men who have sex with men—two U.S. cities, 2012–2014. Sex Transm Dis. 2019; 46:657–662.
3.
WeyersS, GarlandSM, CruickshankM, et al.Cervical cancer prevention in transgender men: a review. BJOG. 2021; 128:822–826.
4.
NewcombME, HillR, BuehlerK, et al.High burden of mental health problems, substance use, violence, and related psychosocial factors in transgender, non-binary, and gender diverse youth and young adults. Arch Sex Behav. 2020; 49:645–659.
5.
ReisnerSL, MurchisonGR. A global research synthesis of HIV and STI biobehavioural risks in female-to-male transgender adults. Glob Public Health. 2016; 11:866–887.
6.
OldenburgCE, Perez-BrumerAG, ReisnerSL. Poverty matters: contextualizing the syndemic condition of psychological factors and newly diagnosed HIV infection in the United States. AIDS Lond Engl. 2014; 28:2763–2769.
7.
Perez-BrumerA, NunnA, HsiangE, et al.“We don't treat your kind”: assessing HIV health needs holistically among transgender people in Jackson, Mississippi. PLoS One. 2018; 13:e0202389.
8.
LoSchiavoC, GreeneRE, HalkitisPN. Human papillomavirus prevalence, genotype diversity, and risk factors among transgender women and nonbinary participants in the P18 Cohort Study. AIDS Patient Care STDs. 2020; 34:502–505.
9.
ApaydinKZ, FontenotHB, ShtaselD, et al.Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center. Vaccine. 2018; 36:3868–3875.
10.
BednarczykRA, WhiteheadJL, StephensonR. Moving beyond sex: assessing the impact of gender identity on human papillomavirus vaccine recommendations and uptake among a national sample of rural-residing LGBT young adults. Papillomavirus Res. 2017; 3:121–125.
11.
JamesSE, HermanJL, RankinS, et al.The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality, 2016.
12.
PoteatT, GermanD, KerriganD. Managing uncertainty: a grounded theory of stigma in transgender health care encounters. Soc Sci Med. 2013; 84:22–29.
13.
KcomtL, GoreyKM, BarrettBJ, McCabeSE. Healthcare avoidance due to anticipated discrimination among transgender people: a call to create trans-affirmative environments. SSM - Popul Health. 2020; 11:100608.
14.
TestaRJ, HabarthJ, PetaJ, et al.Development of the gender minority stress and resilience measure. Psychol Sex Orientat Gend Divers. 2015; 2:65–77.
15.
McReeAL, GowerAL, ReiterPL. Preventive healthcare services use among transgender young adults. Int J Transgend. 2018; 19:417–423.
16.
KastingML, GiulianoAR, ChristySM, et al.Human papillomavirus vaccination prevalence among adults aged 19–45 years: an analysis of the 2017 National Health Interview Survey. Am J Prev Med. 2020; 59:837–849.
17.
Department of Health and Human Services. Increase the proportion of adolescents who get recommended doses of the HPV vaccine—IID-08. Healthy People, 2030. Available at: https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/increase-proportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08 Accessed November22, 2021.
18.
StroumsaD, ShiresDA, RichardsonCR, et al.Transphobia rather than education predicts provider knowledge of transgender health care. Med Educ. 2019; 53:398–407.
19.
Advisory Committee on Immunization Practices. Recommendations on the use of quadrivalent human papillomavirus vaccine in males, 2011. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm Accessed April19, 2021.
20.
BoersmaP, BlackLI. Human papillomavirus vaccination among adults aged 18–26, 2013-2018. NCHS Data Brief. 2020; 1–8.
